• IN8bio therapy doubles progression free survival in brain cancer trial TipRanks Thu, 09 Jul 2026 13:57:41 GMT
• IN8bio publishes phase 1 glioblastoma trial results in JCO Investing.com Thu, 09 Jul 2026 13:23:08 GMT
• IN8bio Announces Publication in The Journal of Clinical GlobeNewswire Thu, 09 Jul 2026 12:00:00 GMT
• IN8bio publication says brain tumor therapy doubled progression-free survival Stock Titan Thu, 09 Jul 2026 12:00:00 GMT
• IN8bio Inc updates its immunotherapy pipeline as Nasdaq-listed biotech navigates clinical milestones AD HOC NEWS Tue, 07 Jul 2026 11:59:39 GMT
• IN8bio stock centers on clinical programs. The Nasdaq listing stays the key anchor. AD HOC NEWS Fri, 03 Jul 2026 18:45:19 GMT
• IN8bio Inc. (INAB) Edges Higher as Biotech Sector Shows Renewed Interest - On Balance Volume dars.gov.et Thu, 02 Jul 2026 15:44:24 GMT
• Enterprise value to EBITDA forward of IN8bio, Inc. – NASDAQ:INAB TradingView Tue, 30 Jun 2026 06:43:16 GMT
• in8bio inc. (inab) q1 2026 earnings: narrowed loss surpasses expectations as clinical pipeline advances - revenue estimate trend dars.gov.et Sun, 28 Jun 2026 21:40:03 GMT
• INAB Q1 2026 Earnings: EPS Beat by 63% Highlights Improved Cost Management - Final Results dars.gov.et Sat, 27 Jun 2026 19:32:42 GMT
• enterprise value to ebitda forward of in8bio, inc. – swb:6jh0 TradingView Fri, 26 Jun 2026 07:54:39 GMT
• Enterprise value to revenue forward of IN8bio, Inc. – NASDAQ:INAB TradingView Thu, 25 Jun 2026 18:55:33 GMT
• enterprise value to ebit forward of in8bio, inc. – swb:6jh0 TradingView Thu, 25 Jun 2026 18:31:32 GMT
• in8bio, inc. (inab) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 00:03:27 GMT
• in8bio, inc. (inab) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 23:04:04 GMT
• in8bio, inc. (inab) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:18:34 GMT
• in8bio, inc. (inab) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 19:59:31 GMT
• IN8BIO, Inc. (INAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 19:51:53 GMT
• in8bio, inc. (inab) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:54:04 GMT
• in8bio, inc. (inab) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 17:51:31 GMT
• in8bio, inc. (inab) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 17:50:38 GMT
• in8bio inc stock (us45332y1001): analyst coverage and valuation in focus Ad-hoc-news.de Mon, 15 Jun 2026 13:49:53 GMT
• in8bio, inc. (inab) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• inab q1 2026 earnings: narrower loss beats expectations, stock rises - mid-term outlook newsline.com Thu, 11 Jun 2026 22:36:12 GMT
• 12 health care stocks moving in thursday's after-market session Benzinga Thu, 11 Jun 2026 21:05:53 GMT
• inab q1 2026 earnings: significant eps beat despite lack of revenue, stock declines - fiscal year earnings newsline.com Thu, 11 Jun 2026 11:43:00 GMT
• in8bio inc stock (us45332y1001): q1 2026 update keeps focus on gamma-delta t?cell pipeline Ad-hoc-news.de Mon, 08 Jun 2026 07:00:00 GMT
• in8bio (inab) may find a bottom soon, here's why you should buy the stock now MSN Sun, 07 Jun 2026 15:01:33 GMT
• in8bio (inab) declines sharply amidst biotech sector weakness - fear greed extreme dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• inab q1 2026 earnings: narrower-than-expected loss drives positive surprise - trough earnings signal newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• in8bio (inab) may find a bottom soon, here's why you should buy the stock now MSN Fri, 05 Jun 2026 06:05:39 GMT
• IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• Trial data back glioblastoma treatment’s potential to extend survival Rare Cancer News Thu, 04 Jun 2026 07:00:00 GMT
• h.c. wainwright reiterates in8bio stock rating, $6 target on trial data Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Ther... GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• Nature review spotlights off-the-shelf γδ T cell cancer therapies Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: revolution medicines (rvmd), in8bio (inab) and polypid (pypd) The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• in8bio, inc. enters capital on demand™ sales agreement with jonestrading – form 8-k filing details Minichart Tue, 02 Jun 2026 07:00:00 GMT
• in8bio, inc. enters capital on demand™ sales agreement with jonestrading – form 8-k filing details minichart.com.sg Mon, 01 Jun 2026 16:20:00 GMT
• IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026 GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• IN8bio Establishes At-The-Market Equity Offering With JonesTrading, 3% Sales Commission TradingView Mon, 01 Jun 2026 07:00:00 GMT
• IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering TradingView Mon, 01 Jun 2026 07:00:00 GMT
• in8bio (nasdaq: inab) launches new atm stock program, ends cantor deal Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• in8bio enters new at-the-market sales agreement, ends prior equity deal Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• brain cancer trial: in8bio therapy tops 19.5 months vs 13.2 Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• in8bio (inab) registers $2.8m at-the-market program with jonestrading Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• in8bio inc stock (us45332y1001): nasdaq biotech shares edge higher as analyst consensus points to ho AD HOC NEWS Mon, 01 Jun 2026 07:00:00 GMT
• inab q1 2026 earnings: eps surprise of 63% exceeds expectations amid pre-revenue stage - profit warning alert newsline.com Fri, 29 May 2026 07:00:00 GMT
• charitable transfer drops in8bio (inab) fairbairn stake below 5% threshold Stock Titan Fri, 29 May 2026 07:00:00 GMT
• in8bio (nasdaq: inab) director makes 724,637-share charitable stock gift Stock Titan Fri, 29 May 2026 07:00:00 GMT
• in8bio inc. (inab) rallies 3.89% as biotech sentiment turns bullish amid key resistance test - negative gamma newsline.com Fri, 29 May 2026 07:00:00 GMT
• inab q1 2026 earnings: narrowed losses exceed expectations as clinical progress continues - gaap earnings report newsline.com Thu, 28 May 2026 07:00:00 GMT
• in8bio inc. (inab) q1 2026 earnings: narrowed loss beats expectations, stock rises - tax rate impact The Legal Advocate Wed, 27 May 2026 16:37:07 GMT
• IN8bio Inc. (INAB) Surges Over 8%: Breaking Through Key Levels with Strong Momentum - Last Point Resistance dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• in8bio q1 2026 earnings: eps beat drives modest stock gain as development costs remain under control - ebitda margin trends newsline.com Tue, 26 May 2026 07:00:00 GMT
• inab q1 2026 earnings: narrower-than-expected loss as clinical stage company advances pipeline - debt analysis report The Legal Advocate Mon, 25 May 2026 17:33:32 GMT
• in8bio inc. (inab) q1 2026 earnings: eps surprise of 63% highlights cost discipline in pre-revenue biotech The Legal Advocate Mon, 25 May 2026 11:44:14 GMT
• in8bio inc. (inab) edges lower, testing key support at $1.59 amid modest trading - low vol factor newsline.com Mon, 25 May 2026 07:00:00 GMT
• in8bio edges lower as biotech sector faces headwinds - last point support newsline.com Mon, 25 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: in8bio (inab), syndax pharmaceuticals (sndx) and olema pharmaceuticals (olma) The Globe and Mail Sat, 23 May 2026 10:32:00 GMT
• analysts offer insights on healthcare companies: eli lilly & co (lly) and in8bio (inab) The Globe and Mail Sat, 23 May 2026 07:00:00 GMT
• jonestrading maintains in8bio(inab.us) with buy rating, maintains target price $5 Moomoo Sat, 23 May 2026 04:22:50 GMT
• jonestrading maintains in8bio(inab.us) with buy rating, maintains target price $5 富途牛牛 Fri, 22 May 2026 14:32:00 GMT
• h.c. wainwright maintains in8bio(inab.us) with buy rating, maintains target price $6 Moomoo Fri, 22 May 2026 07:00:00 GMT
• inab: promising gamma-delta t cell therapies show efficacy in gbm and autoimmune, with strong financial runway TradingView Thu, 21 May 2026 16:49:44 GMT
• can in8bio (inab) sustain its +7.90% momentum this week? 2026-05-21 - mean reversion trade The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• inab: repeat dosing of γδ t cell therapies yields strong survival and immune benefits in gbm TradingView Thu, 21 May 2026 07:00:00 GMT
• in8bio (inab) q1 2026 earnings beat: revenue $n/a, eps $-0.26 - diluted eps report Newser Wed, 20 May 2026 03:44:03 GMT
• in8bio (inab) q1 2026 earnings beat: revenue $n/a, eps $-0.26 - eps consistency score newsline.com Tue, 19 May 2026 07:00:00 GMT
• [s-3/a] in8bio, inc. amended shelf registration statement Stock Titan Mon, 18 May 2026 07:00:00 GMT
• in8bio (inab) q1 2026 earnings surprise: eps $-0.26, up significant - margin expansion trends The Legal Advocate Mon, 18 May 2026 07:00:00 GMT
• inab stock price, quote & chart | in8bio inc (nasdaq:inab) ChartMill Fri, 15 May 2026 07:00:00 GMT
• in8bio stock (us45332y1001): new translational data spotlight glioblastoma program AD HOC NEWS Thu, 14 May 2026 19:40:07 GMT
• in8bio presents new translational data demonstrating deltex dri reshapes the immune landscape in glioblastoma GlobeNewswire Thu, 14 May 2026 07:00:00 GMT
• what in8bio (inab)'s +3.14% jump means for investors 2026-05-14 - bull pennant newsline.com Thu, 14 May 2026 07:00:00 GMT
• in8bio (inab) awards director 22,000 stock options at $1.58 Stock Titan Tue, 12 May 2026 20:30:22 GMT
• in8bio stock (us45332y1001): clinical-stage biotech focused on gamma-delta t cell therapies AD HOC NEWS Tue, 12 May 2026 07:00:00 GMT
• in8bio (inab) cfo receives 56,250 employee stock options at $1.58 strike price Stock Titan Tue, 12 May 2026 07:00:00 GMT
• in8bio (inab) awards 60,000 stock options to president and coo kate rochlin Stock Titan Tue, 12 May 2026 07:00:00 GMT
• in8bio (inab) director receives 22,000 options at $1.58 exercise price Stock Titan Tue, 12 May 2026 07:00:00 GMT
• in8bio (nasdaq: inab) director awarded options on 22,000 shares Stock Titan Tue, 12 May 2026 07:00:00 GMT
• in8bio (nasdaq: inab) evp and cso awarded 54,000 stock options Stock Titan Tue, 12 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: kodiak sciences (kod), in8bio (inab) and ultragenyx pharmaceutical (rare) The Globe and Mail Tue, 12 May 2026 07:00:00 GMT
• in8bio (inab) director awarded stock options on 22,000 shares Stock Titan Tue, 12 May 2026 07:00:00 GMT
• h.c. wainwright maintains in8bio(inab.us) with buy rating, maintains target price $6 Moomoo Mon, 11 May 2026 07:00:00 GMT
• jonestrading initiates in8bio(inab.us) with buy rating, announces target price $5 Moomoo Sat, 09 May 2026 21:21:53 GMT
• jonestrading initiates in8bio(inab.us) with buy rating, announces target price $5 Moomoo Fri, 08 May 2026 13:31:00 GMT
• what in8bio (inab) disclosed about crisis preparedness | inab q4 2025: in8bio beats loss forecast by 28% - revenue inflection poin... newsline.com Fri, 08 May 2026 07:00:00 GMT
• what in8bio (inab) customer metrics tell us about future growth | inab q4 earnings: no revenue, pipeline updates in focus - profit... The Legal Advocate Fri, 08 May 2026 07:00:00 GMT
• in8bio reports q1 2026 results and shareholder votes The Globe and Mail Fri, 08 May 2026 07:00:00 GMT
• mizuho securities maintains in8bio(inab.us) with buy rating, maintains target price $4 Moomoo Fri, 08 May 2026 02:32:00 GMT
• in8bio inc reports results for the quarter ended march 31 - earnings summary TradingView Thu, 07 May 2026 23:31:07 GMT
• IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• in8bio posts brain cancer data: 13 months without progression Stock Titan Thu, 07 May 2026 07:00:00 GMT
• strong gbm survival data and new equity plan for in8bio (nasdaq: inab) Stock Titan Thu, 07 May 2026 07:00:00 GMT
• press release: in8bio reports first quarter 2026 financial results and recent business highlights Moomoo Thu, 07 May 2026 07:00:00 GMT
• cash runway, pipeline and going concern at in8bio (nasdaq: inab) Stock Titan Thu, 07 May 2026 07:00:00 GMT
• in8bio, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• new glioblastoma data headline in8bio's may-june conference run Stock Titan Wed, 06 May 2026 07:00:00 GMT
• the opportunity most miss about in8bio (inab) (momentum building) 2026-05-03 - etf liquidity Newser Sun, 03 May 2026 07:00:00 GMT
• in8bio inc expected to post a loss of 69 cents a share - earnings preview TradingView Wed, 29 Apr 2026 07:00:00 GMT
• inab (in8bio inc.) delivers narrower than expected q4 2025 loss, shares tick higher on positive investor sentiment. - roe Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 05:05:16 GMT
• in8bio inc stock (us45332y1001): is its gamma-delta t cell platform strong enough to unlock biotech AD HOC NEWS Tue, 21 Apr 2026 03:06:24 GMT
• in8bio inc stock (us45332y1001): is its gamma-delta t cell platform strong enough to unlock biotech AD HOC NEWS Mon, 20 Apr 2026 15:27:28 GMT
• tangible book value per share of in8bio, inc. – dus:6jh0 TradingView Sat, 18 Apr 2026 17:22:30 GMT
• inab (in8bio inc.) delivers narrower than expected q4 2025 loss, shares tick higher on positive investor sentiment. - revenue infl... newsline.com Wed, 15 Apr 2026 07:00:00 GMT
• fomo trade: will in8bio inc benefit from green energy policies - weekly stock analysis & risk managed investment signals baoquankhu1.vn Sat, 11 Apr 2026 18:04:18 GMT
• is in8bio (inab) stock growing now | price at $1.42, down 0.70% - call flow alert newsline.com Wed, 08 Apr 2026 07:00:00 GMT
• aug closing: what are the analyst revisions for steel dynamics incis bac prbcl stock a good investment in year - trade volume repo... baoquankhu1.vn Tue, 07 Apr 2026 23:55:57 GMT
• ai stocks: what is keyprls p e ratio telling us - 2026 preearnings & weekly stock breakout alerts baoquankhu1.vn Mon, 06 Apr 2026 22:09:07 GMT
• retail trends: is hppprc a strong candidate for buy and hold - 2026 performance recap & consistent growth equity picks baoquankhu1.vn Mon, 06 Apr 2026 11:26:21 GMT
• jonestrading maintains in8bio(inab.us) with buy rating, maintains target price $5 富途牛牛 Mon, 06 Apr 2026 07:00:00 GMT
• in8bio reports inducement grant under nasdaq listing rule National Today Sat, 04 Apr 2026 07:00:00 GMT
• IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance Fri, 03 Apr 2026 07:00:00 GMT
• two new in8bio hires get stock options for 11,800 shares Stock Titan Fri, 03 Apr 2026 07:00:00 GMT
• in8bio's inducement grant: a tactical move as fda guidance looms in 2026 Bitget Fri, 03 Apr 2026 05:24:47 GMT
• inflation data: how does in8bio inc score in quality rankings - long setup & real-time buy zone alerts baoquankhu1.vn Tue, 31 Mar 2026 23:06:31 GMT
• history review: what are analysts price targets for in8bio inc - weekly trend report & free weekly chart analysis and trade guides... baoquankhu1.vn Tue, 31 Mar 2026 10:50:19 GMT
IN8bio, Inc.(NASDAQ:INAB) 
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. The company develops INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I cli...
Share this website to your friends